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min and 5 minutes respectively. The patient developed respiratory distress syndrome in the first 
few hours. He had inter- and subcostal retractions, grunting, tachypnea (80 breaths per minute), 
nasal flaring and the pulse was 127 beats per minute with a SpO2 under 90% in room air and 
higher than 95% with oxygen supplementation. The treatment with Dexamethasone showed no 
improvement and an urgent Chest X ray was ordered which revealed a left pneumothorax with 
mediastinal shift to the opposite site. ABG revealed severe acidosis. (pH – 7.13, PCO2 – 70, PO2 
– 46 mmHg). In view of impending respiratory failure and shock baby was intubated, the 
pneumothorax was drained. Hemoculture was positive with GBS. The antibiotic therapy 
(Ampicillin/Sulbactam and Amikacin) was started and the patient was carefully monitored.  
Conclusions. In conclusion, although respiratory distress syndrome is rare in near term or term 
newborn, is usually secondary to a parenchimal pathology, being a common case of spontaneous 
pneumothorax in these infants. Early recognition and treatment is life saving. Usual 
manifestation is progressive respiratory difficulty starting soon after birth. 
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Background : Muscular dystrophies (MD) represent a large group of genetic disorders that are 
manifested by progressive increase of muscle weakness. Duchenne muscular dystrophy (DMD) 
is an X-linked disorder and limb-girdle muscular dystrophies (LGMDs) include over thirty 
subtypes, that are classified in autosomal dominant (1A-1H) and recessive (2A-2W). Our aims 
was to highlight the clinical and genetic aspects in MD by reporting two clinical cases with the 
aim of improving the early diagnosis.  
Case report. The study was performed on the basis of the literature review and presentation of 
two clinical cases: a 6-year-old boy with DMD and another 17 years old boy with LGMD. 
Patient G.V. was diagnosed with DMD at the age of 3 years. Electroneuromyography (ENMG) 
and genetic test (deletion of exons 45-52 in the dystrophin gene) confirmed the diagnosis. He has 
the following clinical signs: calf pseudohypertrophy, waddling gait, lordosis, elevated serum 
creatine kinase (CK) - 14 740 U/l, MB fraction – 833 U/l, lactate dehydrogenase (LDH) – 1934 
U/l. Patient M.A. was diagnosed with LGMD at the age of 7 years through ENMG. He presents 
severe motor deficit, waddling gait, hypoplasia of the thigh muscles, permanent asthenia, total 
CK - 486 U/l, MB fraction - 36 U/l, LDH - 358 U/l. He has first-degree disability and 
cardiomyopathy.  
Conclusions. The first signs of MD (DMD and LGMD) occur at early stages, but often are not 
recognized. Genetic counseling and prenatal diagnosis will significantly reduce morbidity and 
mortality, will contribute to the improving of the quality of life. 
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Background. Apert syndrome (AS) is a dominant autosomal genetic disorder caused by 
heterogeneous mutation in FGFR2 genes on chromosome 10q26 and belongs to a group of 
disorders known as craniofacial congenital malformations. AS can promote the premature fusion 
of bones in the skull, hands, and feet. The incidence of infants born with Apert syndrome is 
approximately 1 in 50000 to 80000. In this study is emphasized the importance of clinical and 
genetic approaches in the research on the specific diagnosis in patients with Apert syndrome.   
Case report. The clinical particularities of Apert syndrome are determined by craniosynostosis 
result from the premature fusion of the skull bones. The child present following clinical features: 
short anterioposterior diameter with high forehead and flat occiput, flat facies, shallow orbits, 
proptosis, hypertelorism, small nose, maxillary hypoplasia, a cleft palate, low set ears, and 
cutaneous syndactyly of the fingers and toes. The neuroimaging of the head revealed 
craniosynostosis of the skull bones. The diagnosis of Apert syndrome was confirmed by clinical 
manifestations and paraclinical investigations. The treatment of Apert syndrome is directed 
toward the specific symptoms that are apparent in each individual.  
Conclusions. Clinical and genetic approaches during genetic counseling combined with a 
number of new methods of neonatal diagnosis in patients with Apert syndrome can reduce the 
frequency of chromosomal abnormalities and congenital malformations. 
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Background. Many patients with complex scalp and skull defects can benefit from scalp 
reconstruction using the trapezoid flap, reducing the morbidity of the donor site. The trapezius 
flap was first reported by Nakajima and Fujino in 1984. It was originally described as a 
myocutaneous or muscle flap, and it has also been used as a free flap. The blood that supply the 
trapezium muscle and the skin is mainly from the superficial and descending branches of the 
transverse cervical artery as well as the occipital artery. 
Case report. This work presents the clinical case of a 65-year-old woman who was diagnosed 
with cornified pluristrative squoamos cancer with bone destruction and invasion to confluence 
sinus and left transverse venous sinus, who underwent the occipital extra-intracranial tumor 
removal. She addresses to our clinic with a massive defect of 10 by 18 cm. After making the 
operative planning, we decided to solve the case with distal trapezius muscle flap. 
Conclusions. The decision of the reconstructive technique should be taken into account with 
regarding to its consequences on the affected anatomical structures, the personal pathological 
antecedents and pre-existing lesions at the level of the donor area. 
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